FIP1L1-PDGFRα D842V, a novel panresistant mutant, emerging after treatment of FIP1L1-PDGFRα T674I eosinophilic leukemia with single agent sorafenib

2009127 citationsJournal Article

Authors

Good health and well-being

Published in: Leukemia

Volume 23, Issue 5, pp. 845-851

Field-Weighted Citation Impact: 10.76